STRM.BIO Presents First Preclinical Data on a Novel Bone Marrow/Hematopoietic Stem Cell-Targeted Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at ASH 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ STRM.BIO announced today that Dr. Jonathan Thon, Founder and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October.
2018 Keynote Announcement brandeis.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brandeis.edu Daily Mail and Mail on Sunday newspapers.